Association between serum non-high-density lipoprotein cholesterol and cognitive dysfunction after acute ischemic stroke: a cross-sectional study

Association between serum non-high-density lipoprotein cholesterol and cognitive dysfunction after acute ischemic stroke: a cross-sectional study

This study aimed to explore the association between serum non-high-density lipoprotein cholesterol (non-HDL-C) and cognitive dysfunction risk in patients with acute ischemic stroke (AIS). This cross-sectional study enrolled 583 AIS patients. Biochemical markers and lipid profile were collected after...

Full description

Bibliographic Details
Main Authors:	Yinghui Jiao, Tian Tian, Shasha Wei, Chengdong Wang, Lili Wu
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2020-10-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Non-high-density lipoprotein cholesterol Ischemic stroke Cognitive dysfunction Mini-Mental State Examination scale Montreal Cognitive Assessment scale
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020001200612&tlng=en

Similar Items

SCREENING FOR POSTSTROKE COGNITIVE IMPAIRMENT VIA MINI MENTAL STATE EXAMINATION AND MONTREAL COGNITIVE ASSESSMENT SCALE
by: Mirena Valkova, et al.
Published: (2012-10-01)

Soluble ST2 and risk of cognitive impairment after acute ischemic stroke: a prospective observational study
by: Yinwei Zhu, et al.
Published: (2021-05-01)

Evaluation of the Mini-Mental State Examination and the Montreal Cognitive Assessment for Predicting Post-stroke Cognitive Impairment During the Acute Phase in Chinese Minor Stroke Patients
by: Yueli Zhu, et al.
Published: (2020-08-01)

Validation of a modified Chinese version of Mini‐Addenbrooke's Cognitive Examination for detecting mild cognitive impairment
by: Feng‐Feng Pan, et al.
Published: (2022-01-01)

Cognitive dysfunction in normally aging urban older adults: A community-based study
by: Rakesh Kumar Tripathi, et al.
Published: (2011-01-01)

Validation of Brain Health Test-7 for Detecting Patients with Mild Cognitive Impairment and Early Dementia
by: Mei- Xian Loi, et al.
Published: (2020-01-01)

High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population
by: Zhang Y, et al.
Published: (2021-05-01)

Assessment of Cognitive Functioning in Adult Women with Low Vitamin D Level Using Mini Mental State Examination and Montreal Cognitive Assessment
by: Aslı Gençay Can, et al.
Published: (2017-04-01)

Mild cognitive impairment in maintenance hemodialysis patients: a cross-sectional survey and cohort study
by: Pei XH, et al.
Published: (2018-12-01)

The effect of five activities daily living on improving cognitive function in ischemic stroke patients
by: Frana Andrianur, et al.
Published: (2023-10-01)

Elevated serum uric acid is associated with cognitive impairment in acute minor ischemic stroke patients
by: Lei Xu, et al.
Published: (2023-10-01)

Screening tests for the evaluation of cognitive impairment in multiple sclerosis patients
by: Alina Ioana Nacu-Florescu, et al.
Published: (2022-12-01)

Comparison between the Mini-Mental State Examination and Montreal Cognitive Assessment as a Cognitive Screening Tool in Patients with Human Immunodeficiency Virus-Associated Neurocognitive Disorders
by: Paulo Roberto Brito-Marques, et al.
Published: (2019-12-01)

Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist’s Perspective
by: Anamaria Jurcau, et al.
Published: (2021-06-01)

Validation of the Conversion between the Mini-Mental State Examination and Montreal Cognitive assessment in Korean Patients with Parkinson’s Disease
by: Ryul Kim, et al.
Published: (2018-01-01)

Association between vitamin D status and cognitive impairment in acute ischemic stroke patients: a prospective cohort study
by: Chen H, et al.
Published: (2018-12-01)

Nonlinear relationship between glycated hemoglobin and cognitive impairment after acute mild ischemic stroke
by: Lei Xu, et al.
Published: (2023-03-01)

Low‐Density Lipoprotein Cholesterol and Risk of Recurrent Vascular Events in Chinese Patients With Ischemic Stroke With and Without Significant Atherosclerosis
by: Kui‐Kai Lau, et al.
Published: (2021-08-01)

Risk factors for decline in Montreal Cognitive Assessment (MoCA) scores in patients with acute transient ischemic attack and minor stroke
by: Lijun Zuo, et al.
Published: (2022-07-01)

Development of a Brief Cognitive Screening Tool for Predicting Postoperative Delirium in Patients with Parkinson’s Disease: A Secondary Analysis
by: Zhou Y, et al.
Published: (2023-09-01)

Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes
by: Jingjing Li, et al.
Published: (2021-12-01)

Usefulness of the Cognitive Composition Test as an Early Discriminator of Mild Cognitive Impairment
by: Yoshiki Tamaru, et al.
Published: (2023-02-01)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
by: Sebastian Bello-Lepe, et al.
Published: (2020-10-01)

Cognitive dysfunction in idiopathic and vascular parkinsonism
by: Ivanka Štenc Bradvica, et al.
Published: (2011-08-01)

The Q* Index: A Useful Global Measure of Dementia Screening Test Accuracy
by: A.J. Larner
Published: (2015-06-01)

Elevated high-density lipoprotein cholesterol and adverse outcomes in women with symptoms of ischemic heart disease
by: Sachini Ranasinghe, et al.
Published: (2024-04-01)

Screening for Impaired Cognitive Domains in a Large Parkinson's Disease Population and Its Application to the Diagnostic Procedure for Parkinson's Disease Dementia
by: Kouichi Ohta, et al.
Published: (2014-05-01)

Comparative Study of Two Short-Form Versions of the Montreal Cognitive Assessment for Screening of Post-Stroke Cognitive Impairment in a Chinese Population
by: Wei J, et al.
Published: (2020-06-01)

Evaluation of retinal and choroidal changes in patients with Alzheimer’s type dementia using optical coherence tomography angiography
by: Ze-Bing Li, et al.
Published: (2021-06-01)

Serum high‐density lipoprotein cholesterol is a protective predictor of executive function in older patients with diabetes mellitus
by: Yue Sun, et al.
Published: (2019-01-01)

Proactive Approach in Detecting Elderly Subjects with Cognitive Decline in General Practitioners’ Practices
by: M. Hanzevacki, et al.
Published: (2011-04-01)

Serum Eicosapentaenoic and Arachidonic Acids Concentration and Cognitive Function in Patients With Coronary Artery Disease
by: Sadegh Yoosefee, et al.
Published: (2021-01-01)

Comparing Diagnostic Accuracy of Cognitive Screening Instruments: A Weighted Comparison Approach
by: A.J. Larner
Published: (2013-03-01)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
by: Peter Willeit, et al.
Published: (2020-12-01)

Estimation of the presence of small dense lipoprotein cholesterol in acute ischemic stroke
by: Yasuhiro Manabe, et al.
Published: (2015-06-01)

High levels of plasma fibrinogen are related to post‐stroke cognitive impairment
by: Yuntao Liu, et al.
Published: (2019-10-01)

A non-linear connection between the total cholesterol to high-density lipoprotein cholesterol ratio and stroke risk: a retrospective cohort study from the China Health and Retirement Longitudinal Study
by: Binhui Xiao, et al.
Published: (2024-03-01)

Serum cystatin C levels are negatively correlated with post-stroke cognitive dysfunction
by: Dao-Xia Guo, et al.
Published: (2020-01-01)

Prognostic significance of moderate cognitive impairment in patients at high and very high cardiovascular risk
by: V. V. Henkel, et al.
Published: (2019-12-01)

Neutrophil to High-Density Lipoprotein Ratio is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
by: Zhang R, et al.
Published: (2022-11-01)